Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

455 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Double-blind, randomized, multicentre, and active comparator controlled investigation of the effect of pioglitazone, metformin, and the combination of both on cardiovascular risk in patients with type 2 diabetes receiving stable basal insulin therapy: the PIOCOMB study.
Hanefeld M, Pfützner A, Forst T, Kleine I, Fuchs W. Hanefeld M, et al. Among authors: fuchs w. Cardiovasc Diabetol. 2011 Jul 14;10:65. doi: 10.1186/1475-2840-10-65. Cardiovasc Diabetol. 2011. PMID: 21756323 Free PMC article. Clinical Trial.
Combined pioglitazone and metformin treatment maintains the beneficial effect of short-term insulin infusion in patients with type 2 diabetes: results from a pilot study.
Musholt PB, Schöndorf T, Pfützner A, Hohberg C, Kleine I, Fuchs W, Hehenwarter S, Dikta G, Kerschgens B, Forst T. Musholt PB, et al. Among authors: fuchs w. J Diabetes Sci Technol. 2009 Nov 1;3(6):1442-50. doi: 10.1177/193229680900300626. J Diabetes Sci Technol. 2009. PMID: 20144400 Free PMC article. Clinical Trial.
The fixed combination of pioglitazone and metformin improves biomarkers of platelet function and chronic inflammation in type 2 diabetes patients: results from the PIOfix study.
Schöndorf T, Musholt PB, Hohberg C, Forst T, Lehmann U, Fuchs W, Löbig M, Müller J, Pfützner A. Schöndorf T, et al. Among authors: fuchs w. J Diabetes Sci Technol. 2011 Mar 1;5(2):426-32. doi: 10.1177/193229681100500233. J Diabetes Sci Technol. 2011. PMID: 21527115 Free PMC article. Clinical Trial.
Effect of pioglitazone and ramipril on biomarkers of low-grade inflammation and vascular function in nondiabetic patients with increased cardiovascular risk and an activated inflammation: results from the PIOace study.
Pfützner A, Hanefeld M, Dekordi LA, Müller J, Kleine I, Fuchs W, Forst T. Pfützner A, et al. Among authors: fuchs w. J Diabetes Sci Technol. 2011 Jul 1;5(4):989-98. doi: 10.1177/193229681100500422. J Diabetes Sci Technol. 2011. PMID: 21880242 Free PMC article. Clinical Trial.
Comparison of the Effects of Pioglitazone versus Placebo when Given in Addition to Standard Insulin Treatment in Patients with Type 2 Diabetes Mellitus Requiring Hemodialysis: Results from the PIOren Study.
Galle J, Kleophas W, Dellanna F, Schmid VH, Forkel C, Dikta G, Krajewski V, Fuchs W, Forst T, Pfützner A. Galle J, et al. Among authors: fuchs w. Nephron Extra. 2012 Jan;2(1):104-14. doi: 10.1159/000337334. Epub 2012 May 4. Nephron Extra. 2012. PMID: 22739963 Free PMC article.
455 results